Amrize Ltd (AMRZ) — SEC Filings
Amrize Ltd (AMRZ) — 13 SEC filings. Latest: 4 (Apr 22, 2026). Includes 6 8-K, 4 4, 2 10-Q.
Overview
Amrize Ltd (AMRZ) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Apr 22, 2026: On April 21, 2026, Amrize Ltd (CIK: 0002035989) filed a Form 4, indicating a statement of changes in beneficial ownership of securities. The filing was accepted on April 22, 2026. The company's mailing address is C/O SPX FLOW in Charlotte, NC, and its business address is in Zug, Switzerland.
Sentiment Summary
Across 13 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 11 neutral. The dominant filing sentiment for Amrize Ltd is neutral.
Filing Type Overview
Amrize Ltd (AMRZ) has filed 1 3, 4 4, 2 10-Q, 6 8-K with the SEC between Jun 2025 to Apr 2026.
Filings by Year
Recent SEC Filings (13)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 22, 2026 | 4 | 4 Filing | |
| Apr 22, 2026 | 4 | Amrize Ltd Files Form 4 for Beneficial Ownership Changes | low |
| Apr 22, 2026 | 4 | Amrize Ltd (AMRZ) Insider Ownership Change | low |
| Apr 22, 2026 | 4 | 4 Filing | |
| Apr 8, 2026 | 3 | 3 Filing | |
| Oct 29, 2025 | 10-Q | Amrize Q3 Net Income Dips Post-Spin-off Amid Revenue Growth | high |
| Oct 28, 2025 | 8-K | Amrize Ltd Files 8-K on Financials and Reg FD | low |
| Aug 7, 2025 | 10-Q | Amrize Q2 Earnings Soar 22% on Strong Revenue Growth | medium |
| Aug 6, 2025 | 8-K | Amrize Ltd. Files 8-K on Financials and Operations | low |
| Jun 23, 2025 | 8-K | Amrize Ltd. Reports Material Changes and Control Shifts | medium |
| Jun 18, 2025 | 8-K | Amrize Ltd. Files 8-K for Financial Obligations | medium |
| Jun 3, 2025 | 8-K | Amrize Ltd Files 8-K | low |
| Jun 2, 2025 | 8-K | Amrize Ltd. (fka Evertect AG) Files 8-K | low |
Risk Profile
Risk Assessment: Of AMRZ's 10 recent filings, 1 were flagged as high-risk, 3 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $3,675M |
| Net Income | $545M |
| EPS | $0.98 |
| Cash Position | $826M |
| Operating Margin | 21.17% |
| Total Debt | $4,932M |
Key Executives
- Donald P. Newman
- 0001282236
- Zug
Industry Context
Amrize Ltd operates in a sector that has seen significant consolidation and strategic realignments, including spin-offs, as companies seek to optimize their portfolios and focus on core competencies. The industry is capital-intensive and subject to cyclical demand, influenced by global economic conditions and infrastructure spending. Competitors are increasingly focused on sustainability and innovation in materials and processes.
Top Tags
corporate-action (3) · insider-filing (2) · ownership-change (2) · company-update (2) · name-change (2) · Spin-off (1) · Building Materials (1) · Financial Performance (1) · Debt Increase (1) · Cash Flow (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenues | $3.675B | Increased by 6.6% for the three months ended September 30, 2025, compared to $3.446 billion in 2024. |
| Net Income Attributable to the Company | $545M | Decreased by 1.4% for the three months ended September 30, 2025, from $553 million in 2024. |
| Net Income Attributable to the Company (YTD) | $887M | Decreased by 9.8% for the nine months ended September 30, 2025, from $983 million in 2024. |
| Operating Income | $778M | Decreased by 7.8% for the three months ended September 30, 2025, from $844 million in 2024. |
| Operating Income (YTD) | $1.431B | Decreased by 13.8% for the nine months ended September 30, 2025, from $1.658 billion in 2024. |
| Cash and Cash Equivalents | $826M | Decreased significantly from $1.585 billion at December 31, 2024, reflecting post-spin-off activities. |
| Long-term Debt | $4.932B | Increased substantially from $980 million at December 31, 2024, due to post-spin-off financing. |
| Basic Weighted-Average Shares Outstanding | 553.1M | Consistent for both three and nine months ended September 30, 2025 and 2024. |
| Diluted EPS | $0.98 | Decreased from $1.00 for the three months ended September 30, 2024. |
| Diluted EPS (YTD) | $1.60 | Decreased from $1.78 for the nine months ended September 30, 2024. |
| Revenue for Q2 2025 | $1.2B | Increased by 15% from $1.04 billion in Q2 2024 |
| Net Income for Q2 2025 | $180M | Increased by 22% from $147.5 million in Q2 2024 |
| Revenue growth percentage | 15% | Year-over-year increase in Q2 2025 revenue |
| Net income growth percentage | 22% | Year-over-year increase in Q2 2025 net income |
| Research and Development spending | $55M | 5% increase in R&D spending, focused on innovative cement technologies |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Amrize Ltd (AMRZ)?
Amrize Ltd has 13 recent SEC filings from Jun 2025 to Apr 2026, including 6 8-K, 4 4, 2 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AMRZ filings?
Across 13 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 11 neutral. The dominant sentiment is neutral.
Where can I find Amrize Ltd SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Amrize Ltd (AMRZ) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Amrize Ltd?
Key financial highlights from Amrize Ltd's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for AMRZ?
The investment thesis for AMRZ includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Amrize Ltd?
Key executives identified across Amrize Ltd's filings include Donald P. Newman, 0001282236, Zug.
What are the main risk factors for Amrize Ltd stock?
Of AMRZ's 10 assessed filings, 1 were flagged high-risk, 3 medium-risk, and 6 low-risk.
What are recent predictions and forward guidance from Amrize Ltd?
Forward guidance and predictions for Amrize Ltd are extracted from SEC filings as they are enriched.